Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 2/20 | 0.55 |
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13397872 | 0.87 | CA12 (0.61) | CA12CA1CA2CA7CA13 | |
| SCHEMBL422539 | 0.86 | MAOA (0.58) | CA12CA1CA2CA7CA13 | |
| SCHEMBL1808815 | 0.85 | CYP3A4 (0.55) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11245186 | 0.85 | MAOA (0.51) | CA12CA1CA2CA7CA13 | |
| SCHEMBL8878775 | 0.83 | MAOA (0.50) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11041011 | 0.83 | MAOA (0.50) | CA12CA1CA2CA7CA13 | |
| SCHEMBL12110770 | 0.80 | MAPK1 (0.50) | CA2MAOAMAOBMAPK1TSHR | |
| SCHEMBL13397873 | 0.80 | CA12 (0.55) | CA12CA1CA2CA7CA13 | |
| SCHEMBL4523181 | 0.80 | SLC6A4 (0.52) | MAOAMAPK1TSHRCYP3A4KMT2A | |
| SCHEMBL10528392 | 0.80 | SLC2A1 (0.55) | CA12CA1CA2CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028594-A | Solar cell, preparation method thereof, photovoltaic module, power utilization device and power generation device | 宁德时代新能源科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-101270068-B | Method for preparing 2-nitryl-4-propylthioaniline | CHANGZHOU YABANG QIHUI PHARMACEUTICAL CHEMICAL ENGINEERING CO LTD | 2011-05-18 | — | — | CN | claimed |
| CN-122028594-A | Solar cell, preparation method thereof, photovoltaic module, power utilization device and power generation device | 宁德时代新能源科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-111448510-B | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | JSR株式会社 | 2023-03-14 | — | — | CN | disclosed |
| CN-111433665-B | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | JSR株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-20210283139-A1 | BIFUNCTIONAL MOLECULES FOR TARGETING UCHL5 | AMPHISTA THERAPEUTICS LIMITED (GB) | 2021-09-16 | — | — | US | disclosed |
| CN-108892643-B | Novel preparation method of albendazole | 常州齐晖药业有限公司 | 2021-01-08 | — | — | CN | disclosed |
| CN-111448510-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | JSR株式会社 | 2020-07-24 | — | — | CN | disclosed |
| CN-111433665-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | JSR株式会社 | 2020-07-17 | — | — | CN | disclosed |
| EP-3653660-A1 | THERMALLY CONDUCTIVE MATERIAL, DEVICE PROVIDED WITH THERMALLY CONDUCTIVE LAYER, THERMALLY CONDUCTIVE MATERIAL FORMATION COMPOSITION, DISC-SHAPED LIQUID CRYSTAL COMPOUND | FUJIFILM Corporation (JP) | 2020-05-20 | — | — | EP | disclosed |
| CN-105733610-B | Composition containing polyamic acid polymer, liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element | JSR株式会社 | 2019-12-17 | — | — | CN | disclosed |
| CN-101270068-B | Method for preparing 2-nitryl-4-propylthioaniline | CHANGZHOU YABANG QIHUI PHARMACEUTICAL CHEMICAL ENGINEERING CO LTD | 2011-05-18 | — | — | CN | disclosed |
| CN-101270091-B | Method for preparing albendazole | CHANGZHOU YABANG QIHUI PHARMACEUTICAL CHEMICAL ENGINEERING CO LTD | 2010-12-29 | — | — | CN | disclosed |
| CN-101270068-A | Method for preparing 2-nitryl-4-propylthioaniline | CHANGZHOU YABANG QIHUI PHARMAC (CN) | 2008-09-24 | — | — | CN | disclosed |
| CN-101270091-A | Method for preparing albendazole | CHANGZHOU YABANG QIHUI PHARMAC (CN) | 2008-09-24 | — | — | CN | disclosed |
| WO-1997013748-A1 | SULFOXIDE DERIVATIVES OF NITROGEN-MUSTARD AND ANTICANCER AGENT CONTAINING THE SAME | CHONG KUN DANG CORP. (KR) | 1997-04-17 | — | — | WO | disclosed |
| US-4791129-A | RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS | PFIZER INC. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4725616-A | ANTIARTHRITIC AGENTS | PFIZER INC. (US) | 1988-02-16 | — | — | US | disclosed |
| EP-0208510-A2 | 1-Substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents | PFIZER INC. (US) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283139-A1 | BIFUNCTIONAL MOLECULES FOR TARGETING UCHL5 | UCHL5, UCHL3, UCHL1 | CA12 4247/4885CA1 4039/4885CA2 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.